NO953883D0 - Rensing av faktor VII - Google Patents

Rensing av faktor VII

Info

Publication number
NO953883D0
NO953883D0 NO953883A NO953883A NO953883D0 NO 953883 D0 NO953883 D0 NO 953883D0 NO 953883 A NO953883 A NO 953883A NO 953883 A NO953883 A NO 953883A NO 953883 D0 NO953883 D0 NO 953883D0
Authority
NO
Norway
Prior art keywords
purification
factor vii
vii
factor
Prior art date
Application number
NO953883A
Other languages
English (en)
Other versions
NO953883L (no
Inventor
Tony Joergensen
Anders H Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953883D0 publication Critical patent/NO953883D0/no
Publication of NO953883L publication Critical patent/NO953883L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6437Coagulation factor VIIa (3.4.21.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21021Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO953883A 1993-03-31 1995-09-29 Rensing av faktor VII NO953883L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner
PCT/DK1994/000122 WO1994022905A1 (en) 1993-03-31 1994-03-24 Purification of factor vii

Publications (2)

Publication Number Publication Date
NO953883D0 true NO953883D0 (no) 1995-09-29
NO953883L NO953883L (no) 1995-11-28

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953883A NO953883L (no) 1993-03-31 1995-09-29 Rensing av faktor VII

Country Status (16)

Country Link
US (1) US5700914A (no)
EP (1) EP0691984A1 (no)
JP (1) JPH08508264A (no)
CN (1) CN1039231C (no)
AU (1) AU677309B2 (no)
CA (1) CA2159313A1 (no)
CZ (1) CZ253395A3 (no)
DK (1) DK38293D0 (no)
FI (1) FI954649A0 (no)
HU (1) HUT72712A (no)
IL (1) IL109164A0 (no)
NO (1) NO953883L (no)
PL (1) PL310887A1 (no)
TW (1) TW278079B (no)
WO (1) WO1994022905A1 (no)
ZA (1) ZA941956B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) * 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
KR100960211B1 (ko) 1998-05-06 2010-05-27 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
PT1257295E (pt) 2000-02-11 2009-07-16 Bayer Healthcare Llc Moléculas de tipo factor vii ou viia
ATE428439T1 (de) * 2001-12-21 2009-05-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzung aus faktor vii polypeptiden
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
PT1517698E (pt) 2002-06-21 2014-11-19 Novo Nordisk Healthcare Ag Composições sólidas estabilizadas de polipéptidos do fator viia
AU2004221758B2 (en) 2003-03-18 2010-07-22 Novo Nordisk Health Care Ag Method for the production of GLA-residue containing serine proteases
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
MXPA05012476A (es) 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
WO2004112828A1 (en) 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
DE602004023848D1 (de) * 2003-07-01 2009-12-10 Novo Nordisk Healthcare Ag Von factor vii polypeptiden
JP5653572B2 (ja) 2003-08-14 2015-01-14 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第vii因子ポリペプチドの液状水性医薬組成物
EP1711513B1 (en) 2003-12-01 2014-07-02 Novo Nordisk Health Care AG Nanofiltration of factor vii solutions to remove virus
WO2005058283A2 (en) * 2003-12-19 2005-06-30 Novo Nordisk Health Care Ag Stabilised compositions of factor vii polypeptides
US9187549B2 (en) * 2004-12-23 2015-11-17 Novo Nordisk Healthcare A/G Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
DE602006015907D1 (de) * 2005-01-14 2010-09-16 Bayer Healthcare Llc Verfahren zur reinigung von factor vii
ES2398574T3 (es) * 2005-07-22 2013-03-20 Bayer Healthcare Llc Activación en solución de factor VII
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
CN101384272B (zh) * 2005-12-20 2013-05-01 杜克大学 用于递送具有增强的药理性质的活性剂的方法和组合物
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
EP2926825A1 (en) 2008-06-27 2015-10-07 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) * 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
EP2908798B1 (en) 2012-10-17 2018-08-22 The Procter and Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
ES2906118T3 (es) * 2016-12-22 2022-04-13 Km Biologics Co Ltd Método cromatográfico para recolectar factor VII de coagulación sanguínea con alto rendimiento

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
NO953883L (no) 1995-11-28
WO1994022905A1 (en) 1994-10-13
EP0691984A1 (en) 1996-01-17
FI954649A (fi) 1995-09-29
TW278079B (no) 1996-06-11
US5700914A (en) 1997-12-23
CA2159313A1 (en) 1994-10-13
JPH08508264A (ja) 1996-09-03
CN1121723A (zh) 1996-05-01
AU677309B2 (en) 1997-04-17
PL310887A1 (en) 1996-01-08
CZ253395A3 (en) 1996-01-17
CN1039231C (zh) 1998-07-22
IL109164A0 (en) 1994-06-24
HUT72712A (en) 1996-05-28
DK38293D0 (da) 1993-03-31
HU9502846D0 (en) 1995-12-28
FI954649A0 (fi) 1995-09-29
AU6423994A (en) 1994-10-24
ZA941956B (en) 1994-09-30

Similar Documents

Publication Publication Date Title
NO953883D0 (no) Rensing av faktor VII
NO961959D0 (no) Rensing av hemoglobin
FI954047A0 (fi) Ihmisen interleukiini-10:n puhdistaminen
NO952593L (no) Fremgangsmåte ved rensing av en glykolopplösning
NO940912D0 (no) Rensing av kuldemedium
HK1001330A1 (en) Purification of fluoropolymers
NO943248L (no) Rensing av naturgass
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI932222A (fi) Elektro-okulografisen tutkimuksen automatisointi
NO953659D0 (no) Anvendelse av ferrocen
DE69605708D1 (de) Reinigung von Pentafluorethan
NO952949D0 (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
NO931399D0 (no) Anvendelse av naturstein
FI950082A0 (fi) Pituusvakautettu uppoumatyyppinen alus
DE69417915D1 (de) Reinigung von uranhexafluorid
NO934854D0 (no) Rensing av naturgass
FI935609A0 (fi) Asymmetrisk hydrering av dihydrofuroimidazolderivat
NO953272L (no) Kombinasjoner av retrovirale inhibitorer
FI1017U1 (fi) Anordning foer produktion av koldioxid foer vaexthus
SE9501790D0 (sv) Hantering av lakan
KR950013629U (ko) 제함기의 제함장치
GB9309400D0 (en) Purification of fluoronucleosides
UA852S (uk) Набір ваз
NO944557D0 (no) Modifikasjon av poröse materialer
FI924615A0 (fi) Mus av en mikrodator